Effects of Soybean Glyceollins and Estradiol in Postmenopausal Female Monkeys

Abstract: Glyceollins are a novel class of soybean phytoalexins with potential cancer-protective antiestrogenic effects. The purpose of this study was to evaluate the estrogen-antagonist effects of glyceollin-enriched soy protein on biomarkers for breast cancer risk. Thirty female postmenopausal cynomolgus macaques were randomized to one of three dietary treatments for 3 wk: 1) estradiol (E2, 1 mg/day) + casein/lactalbumin (control); 2) E2 + soy protein isolate (SPI) containing 194 mg/day isoflavonoids; and 3) E2 + glyceollin-enriched soy protein (GLY) containing 189 mg/day isoflavonoids + 134 mg/day glyceollins. Doses are expressed in calorically scaled human equivalents. Mean serum glyceollin concentrations at 4 h postfeeding were 134.2 ± 34.6 nmol/L in the GLY group and negligible in the SPI group (P = 0.0007). Breast proliferation was significantly increased in the control group (+237%, P = 0.01) but not in the SPI group (+198%, P = 0.08) or GLY group (+36%, P = 0.18). Gene expression of trefoil factor 1 and progesterone receptor, two markers of estrogen receptor activity in breast epithelium, were also significantly higher in the control (P < 0.05 for both) but not in the GLY group. These preliminary findings suggest that soybean glyceollins are natural compounds with potential estrogen-modulating properties in the breast.

[1]  J. Yager,et al.  Estrogen carcinogenesis in breast cancer. , 2006, The New England journal of medicine.

[2]  J. Cline,et al.  Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. , 2006, Cancer research.

[3]  E. Baracat,et al.  Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. , 2006, Maturitas.

[4]  G. Mahady.  Do soy isoflavones cause endometrial hyperplasia? , 2005, Nutrition reviews.

[5]  M. Ronis,et al.  Soy Protein Isolate and Protection Against Cancer , 2005, Journal of the American College of Nutrition.

[6]  S. Cummings,et al.  Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. , 2004, Journal of the National Cancer Institute.

[7]  G. Maskarinec,et al.  A 2-year soy intervention in premenopausal women does not change mammographic densities. , 2004, The Journal of nutrition.

[8]  J. Cline,et al.  Lessons to be learned from animal studies on hormones and the breast. , 2004, Maturitas.

[9]  G. Hartman,et al.  Isoflavonoid accumulation in soybean hairy roots upon treatment with Fusarium solani. , 2004, Plant physiology and biochemistry : PPB.

[10]  J. Cline,et al.  Breast and uterine effects of soy isoflavones and conjugated equine estrogens in postmenopausal female monkeys. , 2004, The Journal of clinical endocrinology and metabolism.

[11]  K. Schneider,et al.  Allometric principles for interspecies extrapolation in toxicological risk assessment--empirical investigations. , 2004, Regulatory toxicology and pharmacology : RTP.

[12]  X. Shu,et al.  Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study , 2004, BMJ : British Medical Journal.

[13]  A. Nardulli,et al.  Fos and Jun inhibit estrogen-induced transcription of the human progesterone receptor gene through an activator protein-1 site. , 2004, Molecular endocrinology.

[14]  X. Shu,et al.  Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  K. Setchell,et al.  Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. , 2003, The Journal of nutrition.

[16]  L. Kolonel,et al.  Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  T. Key,et al.  Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. , 2002, Journal of the National Cancer Institute.

[18]  K. Setchell.  Soy Isoflavones—Benefits and Risks from Nature’s Selective Estrogen Receptor Modulators (SERMs) , 2001, Journal of the American College of Nutrition.

[19]  T. Cleveland,et al.  Phytochemical Glyceollins, Isolated from Soy, Mediate Antihormonal Effects through Estrogen Receptor α and β1 , 2001 .

[20]  P. Goss,et al.  Estrogen and the risk of breast cancer. , 2001, The New England journal of medicine.

[21]  S. Bustin.  Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. , 2000, Journal of molecular endocrinology.

[22]  A. Duncan,et al.  Modest hormonal effects of soy isoflavones in postmenopausal women. , 1999, The Journal of clinical endocrinology and metabolism.

[23]  J. Potter,et al.  Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable, and fruit intake. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  J. Cline,et al.  Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. , 1998, The American journal of clinical nutrition.

[25]  L. Skoog,et al.  Effects of conjugated estrogens, medroxyprogesterone acetate, and tamoxifen on the mammary glands of macaques , 1998, Breast Cancer Research and Treatment.

[26]  D. Ingram,et al.  Case-control study of phyto-oestrogens and breast cancer , 1997, The Lancet.

[27]  L. Kolonel,et al.  Association of soy and fiber consumption with the risk of endometrial cancer. , 1997, American journal of epidemiology.

[28]  R. Bostick,et al.  Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  Thomas T. Y. Wang,et al.  Molecular effects of genistein on estrogen receptor mediated pathways. , 1996, Carcinogenesis.

[30]  R W Blamey,et al.  A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. , 1995, Human pathology.

[31]  R. Miksicek.  Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  P. Chambon,et al.  Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  O. Ylikorkala,et al.  Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. , 2005, Fertility and sterility.

[34]  T. Cleveland,et al.  Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta. , 2001, The Journal of clinical endocrinology and metabolism.

[35]  L. Skoog,et al.  Regional distribution of proliferating cells and hormone receptors in the mammary gland of surgically postmenopausal macaques. , 1997, Gynecologic and obstetric investigation.

[36]  G Block,et al.  Phytoestrogen content of foods--a compendium of literature values. , 1996, Nutrition and cancer.

[37]  S. Veronese,et al.  Detection of Ki-67 proliferation rate in breast cancer. Correlation with clinical and pathologic features. , 1991, American journal of clinical pathology.